458 related articles for article (PubMed ID: 32639848)
1. The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19.
Ye Q; Wang B; Zhang T; Xu J; Shang S
Am J Physiol Gastrointest Liver Physiol; 2020 Aug; 319(2):G245-G252. PubMed ID: 32639848
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.
Galanopoulos M; Gkeros F; Doukatas A; Karianakis G; Pontas C; Tsoukalas N; Viazis N; Liatsos C; Mantzaris GJ
World J Gastroenterol; 2020 Aug; 26(31):4579-4588. PubMed ID: 32884218
[TBL] [Abstract][Full Text] [Related]
4. Direct SARS-CoV-2 infection of the heart potentiates the cardiovascular sequelae of COVID-19.
Bose RJC; McCarthy JR
Drug Discov Today; 2020 Sep; 25(9):1559-1560. PubMed ID: 32592868
[No Abstract] [Full Text] [Related]
5. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus Disease (COVID-19) and the Gastrointestinal System in Children.
Matthai J; Shanmugam N; Sobhan P;
Indian Pediatr; 2020 Jun; 57(6):533-535. PubMed ID: 32562397
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes.
Loganathan S; Kuppusamy M; Wankhar W; Gurugubelli KR; Mahadevappa VH; Lepcha L; Choudhary AK
Respir Physiol Neurobiol; 2021 Jan; 283():103548. PubMed ID: 32956843
[TBL] [Abstract][Full Text] [Related]
8. Covid-19 and the digestive system.
Wong SH; Lui RN; Sung JJ
J Gastroenterol Hepatol; 2020 May; 35(5):744-748. PubMed ID: 32215956
[TBL] [Abstract][Full Text] [Related]
9. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
Ahlawat S; Asha ; Sharma KK
Virus Res; 2020 Sep; 286():198103. PubMed ID: 32717345
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
Sanchis-Gomar F; Lavie CJ; Morin DP; Perez-Quilis C; Laukkanen JA; Perez MV
Am J Cardiovasc Drugs; 2020 Oct; 20(5):413-418. PubMed ID: 32737841
[TBL] [Abstract][Full Text] [Related]
11. Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection.
Trottein F; Sokol H
Cell Rep; 2020 Jul; 32(3):107915. PubMed ID: 32649864
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.
Pang X; Cui Y; Zhu Y
Acta Pharmacol Sin; 2020 Sep; 41(9):1255-1257. PubMed ID: 32581256
[No Abstract] [Full Text] [Related]
13. Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells.
Lee S; Yoon GY; Myoung J; Kim SJ; Ahn DG
Emerg Microbes Infect; 2020 Dec; 9(1):2169-2179. PubMed ID: 32969768
[TBL] [Abstract][Full Text] [Related]
14. COVID-19: Focus on the lungs but do not forget the gastrointestinal tract.
Smyk W; Janik MK; Portincasa P; Milkiewicz P; Lammert F; Krawczyk M
Eur J Clin Invest; 2020 Sep; 50(9):e13276. PubMed ID: 32406522
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review.
Cha MH; Regueiro M; Sandhu DS
World J Gastroenterol; 2020 May; 26(19):2323-2332. PubMed ID: 32476796
[TBL] [Abstract][Full Text] [Related]
16. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.
Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK
Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.
Parasa S; Desai M; Thoguluva Chandrasekar V; Patel HK; Kennedy KF; Roesch T; Spadaccini M; Colombo M; Gabbiadini R; Artifon ELA; Repici A; Sharma P
JAMA Netw Open; 2020 Jun; 3(6):e2011335. PubMed ID: 32525549
[TBL] [Abstract][Full Text] [Related]
18. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection.
Zhang H; Li HB; Lyu JR; Lei XM; Li W; Wu G; Lyu J; Dai ZM
Int J Infect Dis; 2020 Jul; 96():19-24. PubMed ID: 32311451
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19.
Patel KP; Patel PA; Vunnam RR; Hewlett AT; Jain R; Jing R; Vunnam SR
J Clin Virol; 2020 Jul; 128():104386. PubMed ID: 32388469
[TBL] [Abstract][Full Text] [Related]
20. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
